Bio Protocol vs Nervos Network — how do they compare? Bio Protocol trades at Rp516.61 (market cap Rp1,15T, Rp264,79M 24h volume), while Nervos Network trades at Rp16.38 (market cap Rp799,32M, Rp39,69M 24h volume). The key difference: Bio Protocol is far larger — about 1438.7× Nervos Network's market cap, and Bio Protocol's supply is capped (2,2B / 3,3B BIO (68%)) while Nervos Network's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 16 Days and Nervos Network for 48 Days on average.
| BIO | CKB | |
|---|---|---|
Market Cap | Rp1,15T | Rp799,32M |
Volume (24h) | Rp264,79M | Rp39,69M |
Circulating Supply | 2,2B / 3,3B BIO (68%) | 49,1B CKB |
Typical Hold Time | 16 Days | 48 Days |
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp514.67 with a market cap of Rp1.15 trillion, showing a bearish technical signal as moving averages indicate selling pressure. The token's circulating supply is 2.2 million out of 3.3 million, with a 68% circulation rate and average hold time of 16 days. Recent news highlights participation in blockchain and tech events, though no major protocol upgrades were reported in the last month.
Overall outlook remains cautious due to bearish technicals and neutral oscillators. Key opportunities include potential rebound from oversold RSI levels near support at Rp474. Major risks involve low liquidity, regulatory uncertainty in Indonesia, and high volatility typical of small-cap cryptocurrencies.
Nervos Network (CKB) is currently trading at Rp16.377 with a market cap of Rp797.56 million, showing bearish technical signals across multiple indicators. The asset faces selling pressure with moving averages indicating a downtrend while oscillators remain neutral. Support and resistance levels are tightly clustered around Rp16-17, suggesting limited price movement range in the short term.
Overall outlook remains cautious with technical indicators favoring sellers. Key opportunities include potential bounce from support levels, while major risks involve continued bearish momentum and limited liquidity. Investors should monitor network activity and broader crypto market sentiment for directional cues.
What Pluang investors did over the last 30 days
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →Nervos Network (CKB) is an open-source public blockchain ecosystem. Its goal is to create a peer-to-peer (P2P) crypto-economy network where users can access a wide range of provably secure blockchain services and capabilities.
Read more on CKB →